Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Joss

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, K Buser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancerJ C Ruckdeschel, D M Finkelstein, D S Ettinger, et al.
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|January 1, 1988
The significance of overhanging filling margins for the health status of interdental periodontal tissues of young adultsN P Lang, D Kaarup-Hansen, A Joss, et al.
Journal of Obesity|May 8, 2014
Intrauterine growth restriction increases TNF α and activates the unfolded protein response in male rat pupsEmily S Riddle, Michael S Campbell, Brook Y Lang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, P Alberto, C Hürny, et al.
Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, P Alberto, E A Bleher, et al.
Schweizerische Medizinische Wochenschrift|May 16, 1987
[Hodgkin's disease in a Swiss family]M F Fey, R A Joss, W J Pichler, et al.
Cancer|June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment centerR A Joss, K Bürki, P Dalquen, et al.
International Journal of Cancer|September 30, 1992
Prevalence of the Rhesus-negative phenotype in Caucasian patients with small-cell lung cancer (SCLC)T Cerny, M F Fey, R Oppliger, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, K Buser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1986
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancerJ C Ruckdeschel, D M Finkelstein, D S Ettinger, et al.
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|January 1, 1988
The significance of overhanging filling margins for the health status of interdental periodontal tissues of young adultsN P Lang, D Kaarup-Hansen, A Joss, et al.
Journal of Obesity|May 8, 2014
Intrauterine growth restriction increases TNF α and activates the unfolded protein response in male rat pupsEmily S Riddle, Michael S Campbell, Brook Y Lang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, P Alberto, C Hürny, et al.
Cancer Treatment Reports|September 1, 1984
Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposideR A Joss, P Alberto, J P Obrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, P Alberto, E A Bleher, et al.
Schweizerische Medizinische Wochenschrift|May 16, 1987
[Hodgkin's disease in a Swiss family]M F Fey, R A Joss, W J Pichler, et al.
Cancer|June 1, 1990
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment centerR A Joss, K Bürki, P Dalquen, et al.
International Journal of Cancer|September 30, 1992
Prevalence of the Rhesus-negative phenotype in Caucasian patients with small-cell lung cancer (SCLC)T Cerny, M F Fey, R Oppliger, et al.
Pageof 15